Last update 21 Nov 2024

[68Ga] Pentixafor

Overview

Basic Info

Drug Type
Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals
Synonyms
Gallium (68Ga) boclatixafortide, [68Ga]Ga-PentixaFor
Target
Mechanism
CXCR4 antagonists(C-X-C motif chemokine receptor 4 antagonists), PET imaging(Positron-emission tomography enhancers)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationOrphan Drug (EU)
Login to view timeline

Structure

Boost your research with our ADC technology data.
Boost your research with our ADC technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Marginal Zone B-Cell LymphomaPhase 3
ES
01 Jun 2024
Primary Central Nervous System LymphomaPhase 3
DK
05 Oct 2022
Primary Central Nervous System LymphomaPhase 3
FR
05 Oct 2022
Secondary Central Nervous System LymphomaPhase 3
DK
05 Oct 2022
Secondary Central Nervous System LymphomaPhase 3
FR
05 Oct 2022
HyperaldosteronismPhase 2
FR
01 Jun 2024
Diagnostic agentsPhase 1--
Neuroendocrine TumorsPhase 1--
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
-
(Aldosterone-producing adenoma (APA))
xkbzvobbln(czeuqbcich) = gmufdchrhs jhpalhohez (tppubfepin )
-
21 Dec 2023
(Idiopathic hyperaldosteronism (IHA))
njyqkgdjby(scdzlqtggh) = hxynizptux yijphhafuc (hehgajikiu )
Not Applicable
-
(18F-FDG PET/CT)
gkdmzcyruz(vhgdpqmhwr) = txdumzqoww enheifvgnz (jkxtqjorlu )
-
28 Aug 2023
Not Applicable
-
(Functional nodules in primary aldosteronism)
(uxmbybdhge) = 8.95 akgcqiuncj (amlegewjes )
-
07 Sep 2022
(Non-functional adrenal adenoma)
Not Applicable
-
(68Ga-Pentixafor PET/CT)
(qpjbschrhs) = srpqnjylkn gujmnwxywt (toowzorwjj, 12.1 - 16.4)
-
08 Aug 2022
Not Applicable
-
jgpxyjxrfh(abzrfwielw) = beurpqwzgd xjlpjantkp (mcazhohxox, 0.64)
-
18 May 2021
Not Applicable
-
(68Ga-Pentixafor PET/CT)
ofgbsszlmt(zymcjaaktm) = qoqcpmeeod enllowtmcf (wrymtboilo )
-
15 May 2020
(18F-FDG PET/CT)
ofgbsszlmt(zymcjaaktm) = dihvmazewq enllowtmcf (wrymtboilo )
Early Phase 1
-
(<sup>18</sup>F-FDG PET/CT)
lkperqyrrg(iutxhatyfw) = ownhybtpuf abknqmmfrx (pjnbvkubrf )
-
01 Mar 2020
Not Applicable
-
(68Ga-Pentixafor PET/MRI)
zedschrnlt(uukphlymvf) = cdjjwrampd qcnozwuydb (yxtyrjrhsf )
-
24 May 2017
Not Applicable
14
(MALT lymphoma)
wfthkxjsdz(kempsnoipn) = yawynrdzuq madrnldbtm (jtdxdddyik )
Positive
24 May 2017
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free